LK-980
LK-980 is a cholesterol biosynthesis inhibitor. LK-980 primarily inhibits human sterol Δ7-reductase (DHCR7), and more weakly inhibits sterol Δ14-reductase (DHCR14), sterol Δ24-reductase (DHCR24), and sterol C5-desaturase (SC5DL). LK-980 is slowly metabolized in human primary hepatocytes and does not induce CYP3A4 enzyme activity or mRNA expression. LK-980 can be used in research related to cholesterol metabolism disorders such as hyperlipidemia and atherosclerosis, as well as cardiovascular diseases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 943250-95-1
- Formule: C19H25N3O
- Masse moléculaire:311.43
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
LK-980 (1 µM) was slowly metabolized by human primary hepatocytes, with a half-life of 4.32 h in HH-114 and >6 h in HH-089 and HH-129[1].
LK-980 (10 µM; 48 h) primarily inhibits DHCR7 in human primary hepatocytes, increasing 7-dehydrocholesterol by 34.16-fold, while slight increases in FF-MAS, desmosterol, and lathosterol indicate weak inhibition of DHCR14, DHCR24, and SC5DL[1].
LK-980 (10 µM; 12-48 h) does not induce CYP3A4 activity or mRNA in human primary hepatocytes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 943250-95-1
-
Masse moléculaire 311.43
-
Formule C19H25N3O
-
SMILES
OC(C=1C=NC=CC1)CN2CCN(CCC=3C=CC=CC3)CC2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)